Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018

Active surveillance (AS) is becoming a widely adopted strategy for patients affected by low-risk prostate cancer. While a formal systematic review on the topic will soon be available, the European Association of Urology has produced specific statements for different open questions on AS.